Literature DB >> 18483487

The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes.

Andreas Markert1, Michael Grimm, Javier Martinez, Julia Wiesner, Andreas Meyerhans, Oded Meyuhas, Albert Sickmann, Utz Fischer.   

Abstract

The positive transcription elongation factor b (P-TEFb) is a heterodimeric complex composed of cyclin-dependent kinase 9 and its regulator cyclin T1/2. It stimulates transcription elongation by phosphorylation of serine 2 residues in the carboxy-terminal domain of polymerase II. 7SK RNA and HEXIM proteins can antagonize transcriptional stimulation by sequestering P-TEFb in a catalytically inactive ribonucleoprotein (RNP). Here, we show that the previously uncharacterized La-related protein 7 (LARP7) has a role in 7SK-mediated regulation of transcription. LARP7 binds to the highly conserved 3'-terminal U-rich stretch of 7SK RNA and is an integral part of the 7SK RNP. On stimulation, LARP7 remains associated with 7SK RNA, whereas P-TEFb is released. Interestingly, reduction of LARP7 by RNA interference enhances transcription from cellular polymerase II promoters, as well as a TAT-dependent HIV-1 promoter. Thus, LARP7 is a negative transcriptional regulator of polymerase II genes, acting by means of the 7SK RNP system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483487      PMCID: PMC2427381          DOI: 10.1038/embor.2008.72

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  22 in total

Review 1.  Synthesis of the translational apparatus is regulated at the translational level.

Authors:  O Meyuhas
Journal:  Eur J Biochem       Date:  2000-11

Review 2.  The La protein.

Authors:  Sandra L Wolin; Tommy Cedervall
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

Authors:  S H Chao; D H Price
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

4.  Identification of multiple cyclin subunits of human P-TEFb.

Authors:  J Peng; Y Zhu; J T Milton; D H Price
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

Review 5.  Taking a new TAK on tat transactivation.

Authors:  K A Jones
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

6.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Authors:  Y Zhu; T Pe'ery; J Peng; Y Ramanathan; N Marshall; T Marshall; B Amendt; M B Mathews; D H Price
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

7.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.

Authors:  V T Nguyen; T Kiss; A A Michels; O Bensaude
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

8.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

Review 9.  Tackling Tat.

Authors:  J Karn
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

10.  Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.

Authors:  Jasper H N Yik; Ruichuan Chen; Rieko Nishimura; Jennifer L Jennings; Andrew J Link; Qiang Zhou
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

View more
  95 in total

1.  Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.

Authors:  Won-Kyung Cho; Moon Kyoo Jang; Keven Huang; Cynthia A Pise-Masison; John N Brady
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

3.  Transcription control by long non-coding RNAs.

Authors:  Tyler Faust; Alan Frankel; Iván D'Orso
Journal:  Transcription       Date:  2012-03-01

4.  Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription.

Authors:  Namita Kumari; Sergey Iordanskiy; Dmytro Kovalskyy; Denitra Breuer; Xiaomei Niu; Xionghao Lin; Min Xu; Konstantin Gavrilenko; Fatah Kashanchi; Subhash Dhawan; Sergei Nekhai
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

5.  A comprehensive analysis of the La-motif protein superfamily.

Authors:  Cécile Bousquet-Antonelli; Jean-Marc Deragon
Journal:  RNA       Date:  2009-03-19       Impact factor: 4.942

Review 6.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

7.  HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

Authors:  Bijan Sobhian; Nadine Laguette; Ahmad Yatim; Mirai Nakamura; Yves Levy; Rosemary Kiernan; Monsef Benkirane
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

8.  Phosphorylation of HEXIM1 at Tyr271 and Tyr274 Promotes Release of P-TEFb from the 7SK snRNP Complex and Enhances Proviral HIV Gene Expression.

Authors:  Uri R Mbonye; Benlian Wang; Giridharan Gokulrangan; Mark R Chance; Jonathan Karn
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

9.  Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop.

Authors:  Yan Wang; Eugene C Dow; Yao-Yun Liang; Rajesh Ramakrishnan; Hongbing Liu; Tzu-Ling Sung; Xia Lin; Andrew P Rice
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

10.  7SK small nuclear RNA transcription level down-regulates in human tumors and stem cells.

Authors:  Mozhgan Abasi; Zahra Bazi; Samira Mohammadi-Yeganeh; Masoud Soleimani; Vahid Haghpanah; Nosratollah Zargami; Hossein Ghanbarian
Journal:  Med Oncol       Date:  2016-10-17       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.